金石资源(603505) - 2024 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders of the listed company was RMB 60,535,568.14, representing a year-on-year increase of 74.94%[14]. - Operating income for the period was RMB 448,114,391.69, reflecting a significant increase of 166.49% compared to the same period last year[14]. - The net cash flow from operating activities was RMB 57,925,958.90, showing a substantial increase of 318.76% year-on-year[14]. - Total operating revenue for Q1 2024 reached RMB 448,114,391.69, a significant increase of 167.5% compared to RMB 168,155,782.19 in Q1 2023[28]. - Operating profit for Q1 2024 was RMB 70,652,302.10, an increase of 70.7% from RMB 41,363,030.10 in Q1 2023[28]. - Net profit for Q1 2024 amounted to RMB 69,243,857.85, compared to RMB 41,094,956.56 in Q1 2023, reflecting a growth of 68.5%[28]. - The total comprehensive income amounted to ¥62,291,205.08, reflecting a substantial increase from ¥34,057,017.13 in the previous period[29]. - Basic and diluted earnings per share improved to ¥0.10, up from ¥0.06[29]. Assets and Liabilities - Total assets at the end of the reporting period reached RMB 5,448,923,080.15, an increase of 8.68% compared to the end of the previous year[4]. - Total assets as of Q1 2024 were RMB 5,448,923,080.15, up from RMB 5,013,506,192.90 at the end of the previous period, indicating a growth of 8.7%[25]. - Non-current assets totaled RMB 3,618,648,738.15, an increase of 6.5% from RMB 3,397,157,488.53[25]. - Current liabilities decreased slightly to RMB 1,713,000,000.00 from RMB 1,800,000,000.00, reflecting a reduction of approximately 4.8%[25]. - The total liabilities of the company as of the latest report were CNY 3,268,655,250.93, an increase from CNY 2,898,751,899.38 year-over-year[48]. - The total equity attributable to shareholders increased to CNY 1,694,253,757.99 from CNY 1,633,099,366.83, reflecting a growth of approximately 3.7%[48]. - The company's retained earnings rose to CNY 1,025,597,416.85 from CNY 965,061,848.71, marking an increase of approximately 6.7%[48]. Cash Flow - The net cash flow from operating activities for Q1 2024 was CNY 57,925,958.90, compared to CNY 13,832,832.14 in Q1 2023, indicating a substantial improvement[48]. - In Q1 2024, the company reported cash inflows from operating activities of CNY 568,235,473.36, a significant increase from CNY 281,212,916.92 in Q1 2023, representing a growth of approximately 102.2%[48]. - The company incurred cash outflows for investing activities totaling CNY 183,749,341.27 in Q1 2024, down from CNY 324,208,175.83 in Q1 2023, reflecting a decrease of about 43.4%[49]. - Cash inflows from financing activities in Q1 2024 amounted to CNY 434,051,213.97, compared to CNY 606,051,222.09 in Q1 2023, a decline of approximately 28.4%[49]. - The net cash flow from financing activities for Q1 2024 was CNY 208,494,153.38, down from CNY 440,187,159.50 in Q1 2023, indicating a decrease of about 52.7%[49]. - The company reported a net increase in cash and cash equivalents of CNY 82,774,583.29 for Q1 2024, compared to CNY 128,346,092.47 in Q1 2023[49]. Production and Sales - The company produced approximately 56,000 tons of self-produced fluorite concentrate, with sales of about 54,000 tons, indicating a decline compared to the same period last year[10]. - The market price for anhydrous hydrofluoric acid was reported at RMB 11,000-11,500 per ton, up from RMB 9,000-9,500 per ton earlier in the year[10]. - Operating revenue surged by 166.49% due to sales from Jin Ebo fluorochemical anhydrous hydrogen fluoride and trade income from Baotou's "selection and processing integration" project[35]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,097, with the largest shareholder holding 49.71% of the shares[7]. - The weighted average return on net assets increased by 1.12 percentage points to 3.64%[14]. Government Support - The company received government subsidies amounting to RMB 1,086,836.28, which were recognized as regular income due to their ongoing impact on the company's operations[17]. Research and Development - Research and development expenses for Q1 2024 were RMB 7,328,816.44, an increase of 31.8% from RMB 5,557,936.32 in Q1 2023[28]. - The company is focusing on expanding its market presence and enhancing product offerings through new technology developments[35]. - The financial results reflect the successful execution of strategic initiatives, including potential mergers and acquisitions to bolster growth[35].